Introduction
============

Human respiratory syncytial virus (RSV) is a major cause of severe respiratory infections in infants and young children ([@ref-30]). Although RSV infections in healthy adults are generally limited to the upper respiratory tract, symptoms in infants and children include wheezing, cough, bronchiolitis and pneumonia ([@ref-23]). RSV is a member of the newly assigned genus *Orthopneumovirus* in the family *Pneumoviridae* ([@ref-1]). It has a single-stranded negative-sense RNA genome of approximately 15.2 kb, which encodes 11 viral proteins ([@ref-11]). The viral envelope glycoproteins G and F are important for the receptor attachment and viral fusion with the target cell, respectively. Both surface glycoproteins can induce the host immune response ([@ref-52]).

RSV can be divided into two distinct subgroups (RSV-A and RSV-B) ([@ref-29]). Subgroups can be further divided into genotypes based on the gene sequence variability of the second hypervariable region (HVR2) located on the distal third region of the G gene ([@ref-28]). As a result, there are 13 RSV-A genotypes: GA1 to GA7 ([@ref-37]), SAA1 ([@ref-50]), NA1 to NA4 ([@ref-40]; [@ref-13]), and ON1 ([@ref-15]). To date, 22 RSV-B genotypes are GB1 to GB4 ([@ref-37]), SAB1 to SAB4 ([@ref-50]; [@ref-3]), URU1 and URU2 ([@ref-7]), BA1 to BA10 ([@ref-47]), BA-C ([@ref-13]), and THB ([@ref-4]).

Within the past decade, a new genotype of RSV-A identified in Ontario, Canada (ON1) has emerged ([@ref-15]). This genotype is characterized by a 72-nucleotide duplication in the HVR2. ON1 has since been detected in Europe, Africa, Asia, and the Americas ([@ref-13]; [@ref-49]; [@ref-38]). Meanwhile, an RSV-B genotype identified in Buenos Aires, Argentina (BA) similarly contained a 60-nucleotide duplication in the HVR2 ([@ref-46]). BA has subsequently became so prevalent globally that it largely replaced other RSV-B genotypes ([@ref-45]). Gene insertion seen in both RSV-A and RSV-B HVR2 may have affected the antigenicity of the G protein and enabled viral escape from the host immunity, thus mediating their predominance in recent years.

Due to the lack of antivirals or approved vaccines for RSV ([@ref-22]), epidemiological surveillance studies are crucial in understanding RSV transmission and spread. Our previous study described the molecular epidemiology of RSV strains in circulation in Thailand between 2010 and 2011 ([@ref-4]). Here, we characterize recent incidence of RSV infection in Thailand from 2012 to 2015 and examined how the G gene of the circulating strains of RSV are changing, which may explain the persistence of RSV circulation in this region.

Materials and Methods
=====================

Samples
-------

This study was approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University (IRB 609/59). The need for consent was waived by the IRB since this study involved the use of anonymous residual specimens. In all, 3,306 archived and convenient specimens from January 2012 to December 2015 previously subjected to routine respiratory viral screening in our laboratory were tested for the presence of RSV. These samples comprised nasopharyngeal aspirates, nasal swabs, and throat swabs from individuals ≤5 years of age (mean age 2.4 years, male-to-female ratio of 1 to 0.8). Patients presented influenza-like illness (defined as the presence of body temperature \>38 °C and respiratory tract symptoms such as runny nose, cough, sore throat, and difficulty breathing) or were diagnosed with probable RSV infection by the physicians. Samples were from Bangkok (*n* = 1, 222 from King Chulalongkorn Memorial Hospital and Bangpakok 9 International Hospital) and from Khon Kaen province (*n* = 2, 084 from Chum Phae Hospital).

RNA extraction, reverse transcription, and PCR amplification
------------------------------------------------------------

RNA was extracted using the Viral Nucleic Acid Extraction Kit (RBC Bio-science) and cDNA synthesized using an ImProm-II Reverse Transcription System (Promega) according to the manufacturer's instructions. Briefly, RNA and random hexamer primers were incubated at 70 °C for 5 min, followed by extension for 2 h at 42 °C and inactivation at 70 °C for 15 min. The amplification of the partial G (inclusive of the HVR2) and F genes was performed using semi-nested PCR as previously described ([@ref-4]). First-round amplification involved initial denaturation at 94 °C for 3 min; 40 cycles of denaturation at 94 °C for 20 s, annealing at 55 °C for 20 s, and elongation at 72 °C for 90 s; and a final extension at 72 °C for 10 min. Identical amplification parameters were carried out in the second-round PCR for 30 cycles. The PCR amplicons (approximately 840 bp for RSV-A and 720 bp for RSV-B) were visualized by 2% agarose gel electrophoresis and purified PCR products were sequenced.

Sequence comparison and phylogenetic analysis
---------------------------------------------

Nucleotide sequences were visualized using Chromas Lite (v2.01), assembled using SeqMan (DNASTAR), analyzed using the Basic Local Alignment Search Tool (BLAST) program (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>), and aligned using BioEdit (v7.0.9.0) and ClustalW. For genotype assignment, 211 strains of RSV-A (*n* = 117) and RSV-B (*n* = 94) in which the partial nucleotide sequences for the G gene were successfully obtained were subjected to phylogenetic analysis. RSV-A strain A2 (genotype GA1, GenBank accession number [M74568](https://www.ncbi.nlm.nih.gov/nuccore/M74568)) and RSV-B strain B1 (genotype GB1, GenBank accession number [AF013254](http://www.ncbi.nlm.nih.gov/nuccore/AF013254)) served as reference strains. Phylogenetic trees were constructed using the neighbor-joining method implemented in MEGA (v6.0) with 1,000 bootstrap replicates ([@ref-42]). Differences between (inter-) and within (intra-) genotypes were evaluated by pairwise nucleotide distance (*p*-distance) calculations. All RSV sequences obtained from this study were deposited in the GenBank database under the accession numbers [KY327937](http://www.ncbi.nlm.nih.gov/nuccore/KY327937)--[KY328054](http://www.ncbi.nlm.nih.gov/nuccore/KY328054) (RSV-A) and [KY328055](http://www.ncbi.nlm.nih.gov/nuccore/KY328055)--[KY328148](http://www.ncbi.nlm.nih.gov/nuccore/KY328148) (RSV-B).

![Seasonal distribution of RSV detected between 2012 and 2015 in this study.\
The number of samples examined by month is shown as gray peaks (right scale). RSV positive rates (bar graphs) for RSV-A (black line) and RSV-B (red line) are also shown (left scale).](peerj-05-3970-g001){#fig-1}

Predictions of glycosylation sites and positive selection analysis
------------------------------------------------------------------

Deduced amino acid sequences for the partial G gene HVR2 were analyzed for potential N-linked glycosylation sites using the online tool NetNGlyc version 4.0 (<http://www.cbs.dtu.dk/services/NetNGlyc/>). Tests for positive selection were conducted using single-likelihood ancestor counting (SLAC), fixed-effects likelihood (FEL), internal fixed-effects likelihood (IFEL), and random-effects likelihood (REL) models on the Datamonkey server (<http://www.datamonkey.org/>), with the ratio of divergence at nonsynonymous and synonymous sites (dN/dS) calculated using the SLAC model. To avoid an excessive false-positive rate, sites with SLAC, FEL and IFEL *p*-values of \<0.1 were accepted as under positive selection. Sites with REL Bayesian factors of \>50 were also accepted as positively selected sites.

![Phylogenetic tree of RSV-A based on the partial nucleotide sequences of the second hypervariable region (HVR2) of the G gene.\
The phylogenetic tree was constructed using the neighbor-joining algorithm in MEGA 6.0 software. Only bootstrap values \>70% are displayed at the branch nodes. Years of virus isolation are color-coded for 2012 (blue triangle), 2013 (pink diamond), 2014 (green circle), and 2015 (red square). Other genotypes consist of GA1 to GA7, SAA1, NA2 and NA4. The scale bar represents the number of nucleotide substitutions per site between close relatives. The number of strains are in parentheses.](peerj-05-3970-g002){#fig-2}

Results
=======

RSV prevalence
--------------

In this study, RSV was identified in 8.4% (277/3,306) of all samples tested, of which 57.4% (159/277) were RSV-A and 42.6% (118/277) were RSV-B ([Table 1](#table-1){ref-type="table"}). Cyclical pattern was reflected by the predominance of RSV-A in 2012, RSV-B in 2013 and 2014, and the subsequent return of RSV-A predominance in 2015. Co-infection with RSV-A and RSV-B was extremely rare (0.4%, 1/277). RSV infection appeared to peak in the rainy months of July to November with the highest incidence (32%, 24/75) in October 2014 ([Fig. 1](#fig-1){ref-type="fig"}).

10.7717/peerj.3970/table-1

###### RSV identified between 2012 and 2015 from patients with acute respiratory tract infections.

![](peerj-05-3970-g006)

  Year    No. of samples   RSV-positive (%)   Groups       
  ------- ---------------- ------------------ ------------ ------------
  2012    834              94 (11.3)          77 (81.9)    17 (18.1)
  2013    707              50 (7.1)           15 (30)      35 (70)
  2014    864              86 (8.8)           35 (40.7)    41 (59.3)
  2015    901              57 (6.3)           32 (56.1)    25 (43.9)
  Total   3,306            277 (8.4)          159 (57.4)   118 (42.6)

Genotyping and phylogenetic analysis
------------------------------------

Analysis of the partial G gene sequence showed that 41% (48/117) of RSV-A were genotype NA1 ([Fig. 2](#fig-2){ref-type="fig"}). This genotype was predominant in 2012, but was relatively absent thereafter. An additional 58.1% (68/117) of RSV-A were ON1, which co-circulated with NA1 in 2012 and remained the only RSV-A genotype detected from 2013 onward. Only one sample was NA3, which appeared in 2012. For RSV-B, most were BA9 (92.6%, 87/94) ([Fig. 3](#fig-3){ref-type="fig"}). The remainders were BA10 (4.3%, 4/94) and BA-C (3.2%, 3/94), which only appeared in 2012 and 2015. One sample (TH-CU448) was co-infected with RSV-A genotype ON1 and RSV-B genotype BA9.

![Phylogenetic tree of the RSV-B nucleotide sequences based on the second hypervariable region (HVR2) of the G gene.\
The phylogenetic tree was constructed using the neighbor-joining algorithm in MEGA 6.0 software. Bootstrap values \>70% are displayed at the branch nodes. Years of virus isolation are color-coded for 2012 (blue triangle), 2013 (pink diamond), 2014 (green circle), and 2015 (red square). Other genotypes consist of GB1 to GB4, SAB1 to SAB4, URU1, URU2, THB, BA1 to BA3, BA5 and BA6. The scale bar represents the number of nucleotide substitutions per site between close relatives. The number of strains are in parentheses.](peerj-05-3970-g003){#fig-3}

For RSV-A, we found an equally high degree of intra-genotype diversity between NA1 and ON1 ([Table S1](#supp-2){ref-type="supplementary-material"}). The *p*-distances within the NA1 and ON1 genotypes ranged from 0.003 to 0.06 (mean = 0.03). In contrast, the inter-genotype *p*-distance between the ON1 and NA1 was lower (0.050), consistent with their close genetic relatedness. For RSV-B, the *p*-distance among the BA10 strains was 0.010. However, diversity among the BA9 strains was higher (*p*-distances ranged from 0 to 0.067). BA9 and BA10 were more closely related to one another (*p*-distance of 0.062) than to BA-C (*p*-distances of 0.090 and 0.080, respectively).

Mutational analysis
-------------------

The predicted amino acid sequences of RSV-A strains obtained in this study corresponded to residue position 212--298 (based on A2 reference strain numbering). As expected, amino acid alignment revealed that all ON1 possessed 24-residue insertion, of which 23 residues are duplication ([Fig. 4](#fig-4){ref-type="fig"}). Potential N-linked glycosylation site appeared most conserved at N237 among all ON1 (100%, 68/68) and less so for N318 (94.1%, 64/68), but was absent at N251 and N273. Although most (87.5%, 42/48) NA1 strains lost the N237 site due to N237D/Y/G substitution, the majority (62.5%, 30/48) also gained an additional potential glycosylation site at N318. It is noteworthy that NA1 in general possessed either the glycosylation site at N237 or N273, but not both. The lone NA3 identified in this study possessed glycosylation sites at positions N237, N251, and N273.

![Alignment of the deduced amino acid residues encoding the second hypervariable region (HVR2) of the G protein RSV-A strains identified in this study compared to the reference A2 strain.\
The strain genotypes (NA1, ON1, and NA3) are indicated on the right (brackets). The number of additional strains with identical sequence as shown is indicated in parentheses to the right of the strain name. The presence of potential N-linked glycosylation sites are shaded. Asterisks indicate the positions of stop codons. Dots indicate identical residues. Tildes indicate missing residues.](peerj-05-3970-g004){#fig-4}

Alignment of RSV-B amino acid sequence with the reference strain B1 revealed an insertion of 20 residues characteristic for the BA genotypes ([Fig. 5](#fig-5){ref-type="fig"}). Two potential N-linked glycosylation sites, N296 and N310 (based on B1 numbering), were well-conserved in BA9 and BA10, but not BA-C due to T312Y/N substitution. A gain of glycosylation site at N253 was seen in some BA9 strains (TH_CU/B12563/2015 and TH_CU/C5157/2014).

![Alignment of the deduced amino acid residues encoding the second hypervariable region (HVR2) of the G protein RSV-B strains identified in this study compared to the reference B1 strain.\
The strain genotypes (BA9, BA10, and BA-C) are indicated on the right (brackets). The number of additional strains with identical sequences as shown is indicated in parentheses to the right of the strain name. The presence of potential N-linked glycosylation sites are shaded. Asterisks indicate the positions of stop codons. Dots indicate identical residues. Tildes indicate missing residues.](peerj-05-3970-g005){#fig-5}

Selection pressure analysis
---------------------------

The high substitute rate typically seen in the genes encoding viral surface glycoproteins led us to analyze possible selective pressure on the G gene. Using the SLAC model, we found that the overall dN/dS ratios for NA1, ON1, and BA9 were 1.13, 1.11, and 0.65, respectively ([Table 2](#table-2){ref-type="table"}). Four residues (233, 274, 298, and 314) of ON1 were under selection. Among these, the strongly site-specific P274L and L298P substitutions were identified in at least three selection models. Amino acid position 237 of NA1 and position 244 of BA9 were also likely under positive selection pressure, but these sites were identified only by single selection models.

10.7717/peerj.3970/table-2

###### Selection pressure analysis by single-likelihood ancestor counting (SLAC), fixed-effects likelihood (FEL), internal fixed-effects likelihood (IFEL), and random effects likelihood (REL) methods.

![](peerj-05-3970-g007)

  Genotype                                             SLAC     FEL     IFEL     REL                               
  ------------ --------------------------------------- -------- ------- -------- ------- -------- ------- -------- -----------
  NA1 (1.13)   237                                     --       --      --       --      --       --      6.665    97643.700
               273                                     --       --      --       --      66.265   0.084   --       --
               296                                     --       --      --       --      168.21   0.078   --       --
  ON1 (1.11)   233                                     --       --      17.361   0.064                    1.778    50.153
               274[^\*^](#table-2fn1){ref-type="fn"}   10.685   0.050   27.016   0.075   36.324   0.067   --       --
               298[^\*^](#table-2fn1){ref-type="fn"}   21.605   0.002   55.119   0.012   58.489   0.023   14.822   14894.500
               314                                     8.800    0.080   --       --                       --       --
  BA9 (0.65)   244                                     --       --      --       --      67.675   0.040   --       --

**Notes.**

Indicate strong site-specific substitutions with at least three selection models.

Discussion
==========

The muti-year study to investigate the prevalence and genetic diversity of RSV circulating in Thailand was undertaken because of the relative lack of recent prevalence data on RSV infection in this region. The overall frequency of RSV (8.4%) found in respiratory samples in this study was similar to the rates from previous studies in Thailand of 8.1% to 8.9% ([@ref-19]; [@ref-31]). The prevalence of RSV in Thailand appears to be moderate and similar to those reported in Senegal (11.4%) ([@ref-17]), Colombia (8.9%) ([@ref-5]), and the United States (7.7%) ([@ref-18]). Although lower prevalence rates have been reported in Korea (2.7%) ([@ref-33]) and Brazil (2.4%) ([@ref-6]), RSV infection is reportedly frequent in western China (23.7%) ([@ref-24]), the Philippines (19.3%--28.1%) ([@ref-34]; [@ref-27]), Vietnam (23%) ([@ref-53]), Indonesia (23%) ([@ref-41]), and Malaysia (18.4%) ([@ref-10]). A recent single hospital study in Laos identified RSV in as many as 41% of infected children ([@ref-32]). Unfortunately, objective comparison of the true regional prevalence of RSV is often hindered by the differences in the RSV detection rates largely due to sample size and the period of surveillance among these studies. Nevertheless, it is clear that RSV infection contributes to a significant portion of respiratory tract infection among young children.

In our study, RSV-A (57.4%) occurred more frequently than RSV-B and this observation is consistent with previous reports from other countries ([@ref-34]; [@ref-39]; [@ref-16]). Several studies including ours have reported alternating epidemics of RSV-A and RSV-B over time ([@ref-13]; [@ref-34]; [@ref-21]; [@ref-55]). This is not surprising since multiple genotypes of RSV-A and RSV-B are known to co-circulate in a single season and emerging genotypes may replace previously predominant ones in subsequent years ([@ref-39]). It is hypothesized that the periodic shifts in the predominant RSV subgroup are driven by the dynamics of population immunity and subgroup-specific herd immunity ([@ref-8]), whichis analogous to periodic lineage shifts of the influenza B virus over time ([@ref-43]). Although co-infections by both RSV-A and RSV-B have previously been described in multiple regions ([@ref-16]; [@ref-36]; [@ref-26]), it was relatively rare in our study.

Variability in RSV infection depends on geographical region, season, and year. In Southeast Asia, RSV incidence appears to peak during the rainy season (July to November), while relatively low rate of infection occurs during the hot and dry months ([@ref-3]; [@ref-32]; [@ref-53]). This is in contrast to the peak incidence in countries with temperate climates whereby RSV infections are more frequent in the winter months ([@ref-21]; [@ref-35]; [@ref-16]). For RSV-A, NA1 was the major genotype found in our previous study conducted between 2010 and 2011 ([@ref-4]) and was also seen here in 2012. More recently, ON1 has displaced NA1 to become the predominantly circulating RSV-A strain ([@ref-15]; [@ref-49]; [@ref-38]; [@ref-25]), although it does not appear to cause more severe disease than other genotypes ([@ref-35]; [@ref-51]). Our study confirms findings of previous studies in that NA1 and ON1, but not NA3, are frequently identified in Southeast Asia ([@ref-3]; [@ref-54]).

Between 2012 and 2015, RSV-B genotypes BA9, BA10, and BA-C were frequently identified. BA9 appeared in Thailand beginning in 2010 and is now the predominant genotype, while other RSV-B genotypes appeared only sporadically. BA9 and BA10 are commonly identified in Southeast Asia ([@ref-3]; [@ref-44]; [@ref-48]). It is noteworthy that the BA genotypes, like the ON1, only recently emerged to replace all other RSV-B strains ([@ref-45]). Furthermore, the BA genotypes also possessed duplication in the HVR2, which is hypothesized to enhance RSV transmissibility by changing the antigenic epitope and facilitate immune evasion ([@ref-51]).

The relatively high genetic variability associated with the HVR2 was confirmed by the alignment of the predicted amino acid sequences of strains from both RSV subgroups. Of significance was the observed changes in the potential N-linked glycosylation sites, which can alter the antigenic characteristics of the viral surface protein by masking of specific epitopes from the host immunity ([@ref-12]; [@ref-20]). Thus, mutations leading to novel glycosylation sites on viral surface glycoproteins may enable immune evasion. Glycosylation site at N237 was found to be highly conserved in all ON1 strains examined in this study. In contrast, only some NA1 strains possessed N237. A gain in glycosylation at N318 was also observed for some NA1 and ON1. One reason in which NA1 in our study demonstrated more heterogeneity at positions 251 and 318 than in other studies may be attributed to our multiple years of surveillance and larger sample size. The observed variations in the potential N-linked glycosylation sites tend to be genotype-specific, and coincidentally most of the positively selected sites in the G protein were in close proximity to and, in some cases, overlapped with, predicted glycosylation motifs (i.e., at amino acid positions 237 and 274). This suggests that positive selection based on N-linked glycosylation sites may play an important role in driving viral diversity ([@ref-14]) as was shown with residue 274, which is located within an antigenic site and is under positive selection ([@ref-15]; [@ref-9]; [@ref-2]; [@ref-27]). In summary, understanding the genetic variability in the RSV G gene is important in evaluating its evolving pathogenicity and transmission potential.

Conclusion
==========

As the G protein of RSV continues to accumulate novel sequence variations, which alter potential N-linked glycosylation patterns and exert positive selection of critical residues, results from this study provide additional knowledge regarding RSV infection patterns and viral diversity crucial for RSV vaccine development.
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